Stay updated on Dupilumab in AFRS Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in AFRS Clinical Trial page.

Latest updates to the Dupilumab in AFRS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference3%

- Check30 days agoChange DetectedApparent page reversion/reorganization: adding Revision: v3.1.0 while removing several MedlinePlus topic sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, Revision: v3.0.2). This reduces the scope of topics available and marks an updated version.SummaryDifference0.4%

- Check44 days agoChange DetectedVersion bumped to v3.0.2; Back to Top element removed.SummaryDifference0.2%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as important topics such as Drug Safety and Counterfeit Drugs. However, many previously listed locations and drug information have been removed.SummaryDifference3%

- Check73 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in AFRS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in AFRS Clinical Trial page.